ERC Pharma

Gembloux ·KBO/BCE: BE 1002.131.150

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	-1.4%	25.2%	better than 25% of 3351 sector peers
Net result	€-152k	€4k	better than 5% of 3338 sector peers
Equity	€-52k	€23k	better than 8% of 3358 sector peers
Gross operating margin	€-49k	€19k	better than 5% of 3324 sector peers
Total assets	€3.70M	€105k	better than 95% of 3356 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€3.70M
Fixed assets	21/28	€3.24M
Formation expenses	20	€2k
Tangible fixed assets	22/27	€590k
Financial fixed assets	28	€2.65M
Current assets	29/58	€459k
Amounts receivable within one year	40/41	€459k
Cash & bank	54/58	€36
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€3.70M
Equity	10/15	€-52k
Contributions / capital	10/11	€100k
Accumulated profits (losses)	14	€-152k
Amounts payable	17/49	€3.75M
Amounts payable after one year	17	€2.01M
Amounts payable within one year	42/48	€1.74M
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€-49k
Operating result	9901	€-71k
Financial income	75	€2k
Financial charges	65	€83k
Result before taxes	9903	€-152k
Net result for the period	9904	€-152k
Result to be appropriated	9905	€-152k

Summary